Diversify Wealth Management LLC Takes Position in Healthpeak Properties, Inc. $DOC

Diversify Wealth Management LLC purchased a new position in Healthpeak Properties, Inc. (NYSE:DOC) in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 78,199 shares of the real estate investment trust’s stock, valued at approximately $1,250,000.

Other large investors also recently modified their holdings of the company. State Street Corp grew its position in Healthpeak Properties by 1.8% in the 3rd quarter. State Street Corp now owns 49,498,109 shares of the real estate investment trust’s stock valued at $947,889,000 after buying an additional 895,460 shares in the last quarter. JPMorgan Chase & Co. raised its position in shares of Healthpeak Properties by 8.6% during the 4th quarter. JPMorgan Chase & Co. now owns 30,674,812 shares of the real estate investment trust’s stock worth $493,251,000 after buying an additional 2,438,278 shares in the last quarter. Fuller & Thaler Asset Management Inc. lifted its stake in shares of Healthpeak Properties by 19.2% in the 4th quarter. Fuller & Thaler Asset Management Inc. now owns 29,648,260 shares of the real estate investment trust’s stock worth $476,744,000 after acquiring an additional 4,776,056 shares during the period. Geode Capital Management LLC lifted its stake in shares of Healthpeak Properties by 0.6% in the 4th quarter. Geode Capital Management LLC now owns 19,534,041 shares of the real estate investment trust’s stock worth $312,959,000 after acquiring an additional 123,274 shares during the period. Finally, Invesco Ltd. boosted its holdings in shares of Healthpeak Properties by 9.9% in the fourth quarter. Invesco Ltd. now owns 18,298,776 shares of the real estate investment trust’s stock valued at $294,244,000 after acquiring an additional 1,648,012 shares in the last quarter. 93.57% of the stock is owned by institutional investors and hedge funds.

Healthpeak Properties Stock Up 0.3%

DOC stock opened at $21.73 on Thursday. The company has a debt-to-equity ratio of 1.15, a current ratio of 2.96 and a quick ratio of 2.96. The firm has a market capitalization of $14.98 billion, a P/E ratio of 67.92, a P/E/G ratio of 3.36 and a beta of 1.02. Healthpeak Properties, Inc. has a 52-week low of $15.70 and a 52-week high of $22.13. The company’s 50 day simple moving average is $20.36 and its 200-day simple moving average is $18.17.

Healthpeak Properties (NYSE:DOC) last posted its quarterly earnings data on Tuesday, May 5th. The real estate investment trust reported $0.45 EPS for the quarter, topping analysts’ consensus estimates of $0.43 by $0.02. Healthpeak Properties had a net margin of 7.73% and a return on equity of 2.61%. The firm had revenue of $752.95 million during the quarter, compared to analyst estimates of $694.59 million. During the same quarter last year, the business posted $0.46 EPS. The company’s revenue was up 7.1% on a year-over-year basis. Healthpeak Properties has set its FY 2026 guidance at 1.710-1.750 EPS. As a group, equities research analysts anticipate that Healthpeak Properties, Inc. will post 1.75 EPS for the current year.

Healthpeak Properties Dividend Announcement

The firm also recently announced a monthly dividend, which will be paid on Friday, September 25th. Stockholders of record on Monday, September 14th will be given a $0.1017 dividend. This represents a c) annualized dividend and a dividend yield of 5.6%. The ex-dividend date of this dividend is Monday, September 14th. Healthpeak Properties’s dividend payout ratio (DPR) is 381.25%.

Analysts Set New Price Targets

A number of research firms have weighed in on DOC. Wells Fargo & Company upped their target price on Healthpeak Properties from $20.00 to $22.00 and gave the stock an “equal weight” rating in a research report on Wednesday. Evercore cut Healthpeak Properties from an “outperform” rating to an “in-line” rating and set a $21.00 price target on the stock. in a research report on Monday, May 11th. Mizuho boosted their price objective on Healthpeak Properties from $21.00 to $24.00 and gave the stock an “outperform” rating in a research note on Monday, July 6th. Citigroup upped their price objective on Healthpeak Properties from $17.50 to $20.00 and gave the company a “neutral” rating in a report on Tuesday, May 12th. Finally, Barclays began coverage on Healthpeak Properties in a report on Tuesday, July 7th. They set an “equal weight” rating and a $23.00 target price on the stock. Four investment analysts have rated the stock with a Buy rating and fifteen have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $20.62.

Insider Activity at Healthpeak Properties

In other news, insider Scott R. Bohn sold 10,989 shares of Healthpeak Properties stock in a transaction on Tuesday, May 12th. The stock was sold at an average price of $19.45, for a total transaction of $213,736.05. Following the transaction, the insider owned 7,636 shares in the company, valued at approximately $148,520.20. The trade was a 59.00% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. 0.23% of the stock is currently owned by company insiders.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.